Flotillin-1 plays a critical role in H-Ras-induced breast cancer aggressiveness and correlates with poor clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for flotillin-1 as a metastasis biomarker in breast cancer; leaves open clinical validation and therapeutic targeting.
Yong et al. (2015) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: